SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Chaudhuri, V. Norris, K. Kelly, C.-Q. Zhu, C. Ambery, J. Lafferty, E. Cameron, N.C. Thomson, Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils, Pulmonary Pharmacology & Therapeutics, 2014, 27, 1, 62

    CrossRef

  2. 2
    Ilkka T. Harvima, Francesca Levi-Schaffer, Petr Draber, Sheli Friedman, Iva Polakovicova, Bernhard F. Gibbs, Ulrich Blank, Gunnar Nilsson, Marcus Maurer, Molecular targets on mast cells and basophils for novel therapies, Journal of Allergy and Clinical Immunology, 2014,

    CrossRef

  3. 3
    Antonio Di Gennaro, Jesper Z Haeggström, Targeting leukotriene B4in inflammation, Expert Opinion on Therapeutic Targets, 2014, 18, 1, 79

    CrossRef

  4. 4
    C Pergola, J Gerstmeier, B Mönch, B Çalışkan, S Luderer, C Weinigel, D Barz, J Maczewsky, S Pace, A Rossi, L Sautebin, E Banoglu, O Werz, The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP), British Journal of Pharmacology, 2014, 171, 12
  5. 5
    Bettina Hofmann, Dieter Steinhilber, 5-Lipoxygenase inhibitors: a review of recent patents (2010 – 2012), Expert Opinion on Therapeutic Patents, 2013, 23, 7, 895

    CrossRef

  6. 6
    Zuzana Diamant, Gail M. Gauvreau, Don W. Cockcroft, Louis-Philippe Boulet, Peter J. Sterk, Frans H.C. de Jongh, Barbro Dahlén, Paul M. O’Byrne, Inhaled allergen bronchoprovocation tests, Journal of Allergy and Clinical Immunology, 2013, 132, 5, 1045

    CrossRef